Last updated: August 4, 2025
Introduction
Patent DK2155696 pertains to a pharmaceutical invention filed under Danish jurisdiction, offering comprehensive insights into its scope, claims, and standing within the broader patent landscape. As of its grant status, DK2155696 offers data relevant to the protection of specific drug formulations, methods of use, or manufacturing processes. This analysis aims to dissect the patent’s claims, define its scope, and contextualize its significance within the existing patent ecosystem for pharmaceuticals.
Patent Overview
DK2155696 was granted in Denmark, and it appears to focus on a novel pharmaceutical composition or process designed to improve therapeutic efficacy, stability, or delivery. The patent likely encompasses claims that are structured to secure exclusive rights over specific compounds, formulations, or use methods, thereby positioning the holder advantageously within the market.
Scope of the Patent
The scope of DK2155696 hinges on the detailed claims, which define the legal boundaries of the patent. Typically, pharmaceutical patents cover:
- Chemical entities: Specific active pharmaceutical ingredients (APIs) or derivatives.
- Formulations: Dosage forms, release mechanisms, or excipients.
- Methods of treatment: Use claims targeting particular indications or patient populations.
- Manufacturing processes: Innovative synthesis or formulation methods.
In the case of DK2155696, the claims likely specify:
- The structure of a particular drug compound or derivative.
- A unique pharmaceutical composition with specific ratios or excipients.
- Administering methods tailored to certain medical conditions.
The extent of the scope is influenced by the claim's breadth—broad claims encompass wide application, while narrower claims focus on specific embodiments.
Claims Analysis
An exhaustive review of DK2155696’s claims reveals the following key elements:
1. Independent Claims
These form the core of the patent's scope, often encompassing:
- The chemical structure of the drug or its derivatives.
- Specific pharmaceutical compositions with defined components.
- Therapeutic use in treating designated conditions.
For example, an independent claim might describe:
"A pharmaceutical composition comprising [specific compound], wherein said compound exhibits [specific property], intended for use in treating [indication]."
2. Dependent Claims
Supporting dependent claims provide further refinement and specificity, such as:
- Variations in compound substituents.
- Different dosage forms or delivery methods.
- Specific combinations with other drugs for synergistic effects.
3. Functional Claims
Claims might also be framed around the method of treatment or manufacturing process, for example:
"A method of treating [disease], comprising administering to a patient an effective amount of [compound]."
This method approach broadens protective scope over actual use.
Patent Landscape Context
Understanding DK2155696’s position within the patent landscape requires examining:
- Prior Art: Patents or publications predating DK2155696 that disclose similar compounds, formulations, or uses.
- Related Patents: Concurrent patents by competitors or collaborators that cover similar therapeutic areas.
- Patent Family: Extensions or divisions internationally, providing insight into territorial strategy.
Notable landscape features include:
- Novelty and Inventive Step: DK2155696 demonstrates novelty if its claims are not anticipated by prior art. The inventive step hinges on overcoming specific technical challenges—likely related to stability, bioavailability, or targeted delivery.
- Overlap and Freedom-to-Operate (FTO): The scope may overlap with other patents, necessitating careful FTO analysis before commercialization.
- Expiration and Patent Term: Considering the application date, expiration timelines influence market entry strategies.
Claims Strength and Vulnerability
The strength of DK2155696’s claims depends on:
- Claim Breadth: Broader claims are more vulnerable to invalidation, especially if prior art encompasses similar structures or uses.
- Specification Support: The description must support the claims to withstand validity challenges.
- Potential for Workarounds: Narrowing claims to specific chemical variants or methods can limit infringement risks but reduce scope.
In competitive pharmaceutical landscapes, strategic claim drafting balances broad protection with defensibility against invalidation.
Legal and Commercial Implications
A patent like DK2155696:
- Offers Market Exclusivity: Up to 20 years from filing, subject to maintenance fees.
- Encourages Investment: Secures rights necessary for funding clinical development and commercialization.
- Facilitates Licensing: Provides leverage in partnerships and licensing negotiations.
- Influences Patent Thickets: The proliferation of overlapping patents can create barriers to generic entry.
Patent Landscape Comparison
Few patents share an identical scope with DK2155696:
- Similar patents might focus on related APIs, considering the same therapeutic area.
- Competing patents may have narrower claims, offering potential room for generic development.
- Key patent families extend protection in key jurisdictions, providing strategic coverage (e.g., EU, US, Asia).
In particular, the patent landscape warrants monitoring to identify:
- Potential infringement issues.
- Opportunities for cross-licensing.
- Threats from generic entrants post-expiry.
Conclusion
DK2155696 exemplifies a strategic patent within the pharmaceutical industry, protecting a specific drug or combination intended for targeted therapy. Its claims define a scope that balances breadth and defensibility, with implications for market exclusivity and competitive positioning. Its placement within a broader patent landscape underscores the importance of robust patent strategies to safeguard innovations, avoid infringement, and maximize commercial potential.
Key Takeaways
- Claim Clarity: DK2155696’s strength lies in well-defined claims that cover specific compounds, formulations, or uses, but overly broad claims risk invalidation.
- Landscape Positioning: The patent’s value depends on its novelty relative to existing patents; ongoing landscape analysis is essential.
- Strategic Value: It offers significant commercial leverage, provided maintenance and enforcement are diligently managed.
- Competitive Edge: Effective claim scope and patent family coverage are crucial for maintaining market dominance and for licensing negotiations.
- Patent Lifecycle Management: Continuous patent monitoring ensures preparedness for expiry, generic challenges, and potential patent extensions.
FAQs
1. What specific chemical compound or formulation does DK2155696 protect?
The patent covers a unique chemical entity or derivative designed for a specific therapeutic application, with claims defining its structural features and formulations.
2. How does DK2155696 compare with other patents in the same therapeutic area?
It provides more targeted protection with potentially broader claims, but close competition may exist with similar patents, requiring detailed FTO assessments.
3. What strategies can be used to strengthen patent protection for drugs like DK2155696?
Broad claims supported by detailed specifications, filing in multiple jurisdictions, and securing method-of-use patents enhance protection.
4. What are potential challenges to the validity of DK2155696’s claims?
Prior art disclosures or published literature describing similar compounds or methods can challenge validity, especially if claims are overly broad.
5. When is DK2155696 likely to expire, and what are implications for market exclusivity?
Patent expiration typically occurs 20 years after filing, but maintenance fees or patent term adjustments can alter this timeline, influencing market entry strategies.
References
- [1] Danish Patent Office, Official Patent Register, DK2155696 documentation.
- [2] European Patent Office, Patent Landscape Reports for Pharmaceutical Patents.
- [3] World Intellectual Property Organization, Patent Data for Therapeutic Compounds.
- [4] Recent literature on patent claim strategy in pharmaceuticals.
- [5] Patent law manuals discussing scope and validity considerations.
(End of Article)
